filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes in the Company's risk factors from those disclosed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023.
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
Issuer Purchases of Equity Securities
On October 21, 2022, we announced that the Board of Directors had approved a share repurchase program (the "Program") that authorized the repurchase of up to $300 million of common stock, which expires in October 2025. At March 31, 2024, our remaining share repurchase authorization was $290.0 million. Subject to numerous factors, including market conditions and alternative uses of cash, we may conduct discretionary repurchases through open market or privately negotiated transactions, which may include repurchases under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.
The following table summarizes the Company's repurchase activity of common stock under the Program during the quarter ended March 31, 2024.
| Period | Total Number of Shares of Common Stock Purchased (000s) | Average Price Paid Per Share of Common Stock | Approximate Value of Shares that May Yet be Purchased Under the Plans (in millions) | Total number of shares purchased as part of publicly announced plans (000s) | ||||||||||
| January 1, 2024 - January 31, 2024 | — | $ | — | $ | 300.0 | — | ||||||||
| February 1, 2024 - February 29, 2024 | 29 | $ | 350.87 | $ | 290.0 | 29 | ||||||||
| March 1, 2024 - March 31, 2024 | — | $ | — | $ | 290.0 | — | ||||||||
| TOTAL FOR THE QUARTER ENDED MARCH 31, 2024 | 29 | $ | 350.87 | $ | 290.0 | 29 |
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information